Teloduo Tablet 40/20 mg
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
MFDS item code 201907257 · Approved 2019.10.15
This product's status changed to Expired on 2025.10.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and dyslipidemia; inhibition of atherosclerosis progression and cardiovascular risk
This medication is used for patients who need to take telmisartan and rosuvastatin simultaneously. Telmisartan helps reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients over 55 years of age with essential hypertension and a high risk of cardiovascular diseases. Rosuvastatin is used for hypercholesterolemia and associated diseases, reducing cholesterol and LDL-cholesterol levels when dietary management is inadequate, thus slowing the progression of atherosclerosis. It also plays a role in reducing the risk of stroke, myocardial infarction, and vascular reconstruction procedures in men over 50 and women over 60 with cardiovascular disease risk. This medication effectively manages hypertension and hyperlipidemia, improving cardiovascular health.
In a drug interaction study of the active ingredients in this medicine, telmisartan 80mg and rosuvastatin 20mg, in the presence of rosuvastatin, the Cmax of telmisartan was approximately 0.87-fold and its AUC was approximately 1.00-fold; in the presence of telmisartan, the Cmax of rosuvastatin increased approximately 1.71-fold and its AUC increased approximately 1.16-fold. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and closely monitor the patient. This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan/rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When this medicine is administered concomitantly with a thiazide diuretic such as hydrochlorothiazide, it provides an additional blood pressure-lowering effect. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. 3. Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience of administration.
This medication can cause serious harm to the fetus and neonate if administered to pregnant women; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals who are allergic to this medication or its components, pregnant or potentially pregnant women, and breastfeeding women should not take this medication. Do not use this medication in individuals with severe liver impairment, obstructive biliary disease, unexplained extremely high liver enzyme levels, muscle diseases, hereditary angioedema patients, etc. It is preferable not to take this medication for individuals with severe renal impairment, those taking certain immunosuppressants, and patients with diabetes or moderate to severe kidney disorders. Patients at high risk for muscle disease, such as those with renal function decline, hypothyroidism, those with a family or past history of muscle toxicity, alcoholics, elderly patients, and those taking certain medications should be cautious as there is a risk of muscle damage while taking this medication. This medication contains lactose, so individuals with lactose intolerance or specific genetic metabolic disorders should not take it. Elderly patients, individuals with high blood potassium levels or at risk of developing them, those with mildly impaired liver function, heart valve diseases or obstructive cardiomyopathy, ischemic heart disease or cerebrovascular disease, gastrointestinal diseases, and renal artery stenosis patients should use this medication with caution. This medication lowers blood pressure, so caution is needed due to the risk of myocardial infarction or stroke from excessive lowering of blood pressure. If symptoms such as muscle pain, weakness, or cramps occur, consult a doctor immediately and, if necessary, undergo tests to check for muscle damage. Regular liver function tests and muscle enzyme tests are important to detect any abnormal signs early. Interactions may occur when used in conjunction with other antihypertensives or certain lipid-lowering agents, immunosuppressants, diuretics, etc., so be sure to inform your physician about any medications currently being taken. Pregnant or breastfeeding women should not use this medication, and women planning to become pregnant should use appropriate contraceptive methods. Safety in children has not been established and is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, requiring immediate medical attention. Drowsiness or dizziness may occur while taking this medication, so caution is required when driving or operating machinery. Keep out of reach of children and do not transfer the medication to another container for safety.
Headache, positional dizziness, sleep paralysis, increased blood pressure, decreased blood pressure, hypotension, elevated ALT, painful urination, rhinitis, discomfort in the oropharynx, lung disease, unspecified gastrointestinal diseases, benign gastrointestinal neoplasms, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, indigestion, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver dysfunction, liver failure, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, asthenia, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, hypoglycemia, angioedema, hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, facial spasms, sensory abnormalities, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, asthenia, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, palpitations, fatigue, nausea, insufficient effect, cough, palpitations, myalgia, elevated CK, constipation, increased AST, asthenia, arthralgia, fatigue, numbness, sensory abnormalities, discomfort in the chest, nausea, diarrhea, loss of appetite, abdominal bloating, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, hypotension, tachycardia, bradycardia, dizziness, acute renal failure, hypoglycemia, asthenia, hunger, cold sweat, hand tremors, decreased concentration, convulsions, altered consciousness, angioedema, laryngeal edema, shock, hypotension, loss of consciousness, liver dysfunction, jaundice, anaphylaxis-like symptoms, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, insufficient effect, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, asthenia, facial edema, rash, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, asthenia, facial edema, rash, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, asthenia, facial edema, rash, alopecia, conjunctivitis, tinnitus, petechiae, headache, dizziness, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, asthenia, facial edema, rash, alopecia, conjunctivitis, tinnitus, petechiae
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air and light, and it is recommended to keep it at room temperature between 1°C and 30°C. This helps maintain the effectiveness of the medication.
White oval film-coated tablet
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.